Peripheral demyelinating neuropathy and central dysmyelination, as symptoms in patients with SOX10 mutations, underscore the relevance of SOX10 for myelinating glia, including oligodendroglial cells. This evidence concerns the gene SOX10 and demyelinating polyneuropathy.